Patents by Inventor Ravi Ramakrishnan

Ravi Ramakrishnan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adapter for converting between the network configuration protocol (NETCONF) and the technical report 069 (TR-069) protocol
    Patent number: 11968282
    Abstract: One embodiment is directed to an adapter entity comprising a Technical Report 069 (TR-069) protocol automatic configuration server (ACS) module configured to communicate with managed equipment included in a radio access network (RAN) using the TR-069 protocol. The adapter entity further comprises a Network Configuration Protocol (NETCONF) server configured to communicate with an Open Network Automation Platform (ONAP) Software Defined Network Radio instance (SDN-R) of an ONAP management and orchestration (MANO) environment using NETCONF. The adapter entity further comprises a TR-069-to-NETCONF mapper module, communicatively coupled to the TR-069 protocol ACS module and the NETCONF server, configured to dynamically map NETCONF requests and responses to and from TR-069 Protocol requests and responses. The adapter entity is configured to dynamically map NETCONF requests and responses to and from TR-069 Protocol requests and responses. Other embodiments and examples are disclosed.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: April 23, 2024
    Assignee: CommScope Technologies LLC
    Inventors: Devaraj Sambandan, Shanthakumar Ramakrishnan, Ravi Setti, Sharath Chandra Chikka Kempegowda
  • Pharmaceutical process and intermediates 714
    Patent number: 8227622
    Abstract: The invention relates to compounds of formula (X), and salts thereof, and their use as intermediates in improved manufacturing processes for the synthesis of pharmaceutical compound (I): X is ?O, ?N—OH or ?N—OC(O)Me; Y is hydrogen, PhS- or p-chlorophenylsulfanyl; Z is hydrogen or —CH2COOR1 wherein R1 is selected from hydrogen, optionally substituted hydrocarbyl and optionally substituted heterocyclyl.
    Type: Grant
    Filed: July 6, 2010
    Date of Patent: July 24, 2012
    Assignee: AstraZeneca AB
    Inventors: Debra Ainge, Eric Merifield, Colin Thomson, Michael Butters, Ravi Ramakrishnan, Ravi Naidu Rayapati, Parhalad Ray Sharma
  • Pharmaceutical Process and Intermediates 714
    Publication number: 20110046394
    Abstract: The invention relates to compounds of formula (X), and salts thereof, and their use as intermediates in improved manufacturing processes for the synthesis of pharmaceutical compound (I): X is ?O, ?N—OH or ?N—OC(O)Me; Y is hydrogen, PhS- or p-chlorophenylsulfanyl; Z is hydrogen or —CH2COOR1 wherein R1 is selected from hydrogen, optionally substituted hydrocarbyl and optionally substituted heterocyclyl.
    Type: Application
    Filed: July 6, 2010
    Publication date: February 24, 2011
    Inventors: Debra Ainge, Eric Merifield, Colin Thomson, Michael Butters, Ravi Ramakrishnan, Ravi Naidu Rayapati, Parhalad Ray Sharma